scholarly journals Transcatheter Tricuspid Valve-in-Valve Replacement with an Edwards Sapien 3 Valve

2017 ◽  
Vol 44 (3) ◽  
pp. 209-213 ◽  
Author(s):  
Pranav Loyalka ◽  
Angelo Nascimbene ◽  
Benjamin Metz ◽  
Igor D. Gregoric ◽  
Ajay Sundara Raman ◽  
...  
Keyword(s):  
Valve Replacement ◽  
Tricuspid Valve ◽  
Case Reports ◽  
Case Series ◽  
Tricuspid Valve Replacement ◽  
Valvular Stenosis ◽  
Edwards Sapien ◽  
Transcatheter Implantation ◽  
Valve In Valve ◽  
Sapien 3

A few case reports and case series have documented the outcomes in patients with tricuspid bioprosthetic valvular degeneration who underwent transcatheter implantation of the Medtronic Melody and the Edwards Sapien XT and Sapien 3 valves. In this report, we describe the case of a 49-year-old woman with severe bioprosthetic tricuspid valvular stenosis and multiple comorbidities who underwent transcatheter tricuspid valve replacement with a Sapien 3 valve.

scholarly journals Bioprosthetic tricuspid valve stenosis: a case series

2019 ◽  
Vol 3 (3) ◽  
Author(s):  
Kazuhito Hirata ◽  
Toshiho Tengan ◽  
Minoru Wake ◽  
Takanori Takahashi ◽  
Toru Ishimine ◽  
...  
Keyword(s):  
Valve Replacement ◽  
Tricuspid Valve ◽  
Venous Pressure ◽  
Case Series ◽  
Right Heart Failure ◽  
Tricuspid Valve Replacement ◽  
Native Valve ◽  
Late Sequela ◽  
High Doses ◽  
Tricuspid Valve Stenosis

Abstract Background Bioprosthetic tricuspid valve stenosis is a late sequela of tricuspid valve replacement (TVR); however, detailed information regarding its clinical picture is lacking. Case summary Thirty-one patients with bioprosthetic TVR (mean age: 60.5 ± 16.6 years, male/female: 11/20) were followed-up for 79.5 ± 49.1 months (14–188 months). Eleven patients developed bioprosthetic tricuspid valve stenosis (mean tricuspid gradient >5 mmHg) at a median interval of 96 months (interquartile range: 61–114 months). The mean tricuspid gradient at the time of tricuspid valve stenosis diagnosis was 10.9 ± 3.9 mmHg. Although the mid-term tricuspid valve stenosis-free survival was favourable (92.4% at 60 and 78.7% at 84 months), it had declined steeply to 31.5% by 120 months. Ten out of 11 tricuspid valve stenosis patients showed signs of right heart failure (RHF) as manifested by oedema and elevated jugular venous pressure, requiring moderate-to-high doses of diuretics. Diastolic rumble was audible in 10 patients. Five of the 11 tricuspid valve stenosis patients required redo TVR as a result of refractory RHF. Examination of the five excised bioprostheses showed pannus in four, fusion of the commissure in three, native valve attachment in two, and sclerosis in one. Detailed clinical pictures and pathology of the explanted valves in three cases that underwent surgery are presented in this case series. Discussion Bioprosthetic tricuspid valve stenosis is not uncommon after 8 years. Tricuspid valve replacement performed at the second surgery was associated with a higher incidence of bioprosthetic tricuspid valve stenosis.

scholarly journals Transcatheter tricuspid valve‐in‐valve implantation for degenerative surgical bio‐prosthesis using SAPIEN 3: A case series

2021 ◽  
Vol 9 (11) ◽  
Author(s):  
Mann Chandavimol ◽  
Tawai Ngernsritrakul ◽  
Krissada Meemook ◽  
Sirin Apinyasawat ◽  
Tarinee Tangcharoen ◽  
...  
Keyword(s):  
Tricuspid Valve ◽  
Case Series ◽  
Valve In Valve ◽  
Sapien 3 ◽  
Valve Implantation

scholarly journals Transvenous Transcatheter Valve-in-Valve Implantation after Bioprosthetic Tricuspid Valve Failure

2014 ◽  
Vol 41 (5) ◽  
pp. 507-510 ◽  
Author(s):  
Ali Mortazavi ◽  
Ross M. Reul ◽  
Leon Cannizzaro ◽  
Kathryn G. Dougherty
Keyword(s):  
Tricuspid Valve ◽  
Shortness Of Breath ◽  
Tricuspid Valve Replacement ◽  
Thoracic Surgical Procedures ◽  
Edwards Sapien ◽  
Cardiology Clinic ◽  
History Of ◽  
Valve In Valve ◽  
Transcatheter Valve ◽  
Valve Implantation

We describe the case of a 38-year-old man with a history of metastatic testicular cancer who had undergone multiple thoracic surgical procedures, including tricuspid valve replacement with a bioprosthetic valve as a result of tricuspid involvement of his malignancy. He presented at our outpatient cardiology clinic with worsening fatigue, shortness of breath, and peripheral edema, investigation of which revealed severe tricuspid bioprosthesis stenosis with central regurgitation. Because of the patient's medical history, he was considered to be a high-risk surgical candidate. Therefore, transcatheter tricuspid valve-in-valve implantation of a 26-mm Edwards Sapien® valve was attempted through a transjugular approach. The procedure restored tricuspid valvar competence and substantially improved the patient's symptoms. We discuss the technical aspects of this case and briefly review the usefulness of the valve-in-valve technique in the tricuspid position.

scholarly journals Pediatric tricuspid valve replacement with a transcatheter aortic valve (SAPIEN 3)

2020 ◽  
Author(s):  
Afksendiyos Kalangos ◽  
Nataliia Shatelen ◽  
Panagiotis Sfyridis ◽  
Evangelia Dalarizou ◽  
Pipina Bonou
Keyword(s):  
Aortic Valve ◽  
Valve Replacement ◽  
Tricuspid Valve ◽  
Tricuspid Valve Replacement ◽  
Transcatheter Aortic Valve ◽  
Sapien 3

Invasive Hemodynamic Characteristics in Patients Undergoing Transcatheter Tricuspid Valve-In-Valve Implantation for Treatment of Tricuspid Stenosis

2020 ◽  
Vol 11 (4) ◽  
pp. 411-416 ◽  
Author(s):  
Krishan Patel ◽  
Soraya Sadeghi ◽  
Jamil Aboulhosn
Keyword(s):  
Pulmonary Artery ◽  
Valve Replacement ◽  
Tricuspid Valve ◽  
Pulsatility Index ◽  
Diastolic Pressure ◽  
Right Atrial ◽  
Tricuspid Valve Replacement ◽  
Valve In Valve ◽  
The Mean ◽  
Valve Implantation

Background: We sought to describe invasive hemodynamic measurements in patients with tricuspid stenosis (TS) undergoing transcatheter tricuspid valve-in-valve (TVIV) implantation immediately pre- and postimplantation. Development of TS in patients who have undergone surgical tricuspid valve replacement with a bioprosthetic valve is a serious complication that leads to elevated right atrial (RA) pressures and decreased cardiac output. Transcatheter TVIV implantation is a viable alternative to surgical tricuspid valve replacement, but data on the hemodynamic consequences of TVIV for the treatment of severe TS are currently limited to echocardiographic assessment of Doppler-derived gradients. Methods: Eleven patients undergoing transcatheter TVIV implantation with moderate to severe bioprosthetic valve stenosis were selected for retrospective review. Right atrial mean pressure, right ventricular (RV) systolic and end-diastolic pressure, mean diastolic RA-RV pressure gradient, pulmonary artery capillary wedge pressure, pulmonary artery systolic, end-diastolic and mean pressures, and pulmonary artery pulsatility index (PAPi) both before and after transcatheter valve placement were collected from catheterization reports. Results: After transcatheter TVIV implantation, the mean TS gradient decreased significantly ( P < .01), while the mean RV end-diastolic pressure increased ( P = .046). Pulmonary artery pulsatility index also increased as the TS was relieved ( P = .039). Conclusions: Tricuspid valve-in-valve implantation results in immediate relief of TS, leading to increased RV preload with resultant augmentation of RV and pulmonary pressures. Increased PAPi following the procedure demonstrates acute improvement in RV output but remains low due to the failure of the RA pressure to decline significantly immediately following intervention.

Sign in / Sign up

Export Citation Format

Share Document